The global epilepsy
therapeutics market was valued at US$ 12.9 Bn in 2018. It is projected to
expand at a compound annual growth rate (CAGR) of 3.4% from 2019 to 2027
according to a new report published by Transparency Market Research (TMR)
titled “Epilepsy Therapeutics Market Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast, 2019–2027” the report suggests that increase in
the geriatric population and number of epilepsy cases is expected to propel
the epilepsy
therapeutics market in the near
future. North America is expected to dominate the global market, owing to the
rise in patient population, high geriatric population, and availability of
advanced drugs. The market in Asia Pacific is expected to expand at a CAGR of
4.4% during the forecast period, due to the increasing geriatric population,
rising awareness, and growing patient population in the region. Moreover,
research and development activities and initiatives by governments in the
healthcare sector are anticipated to further boost the market in Asia Pacific.
Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2448
Value added features
in epilepsy therapeutics to fuel global market
The global epilepsy
therapeutics market is expected to be driven by the advanced and high efficacy
epilepsy therapeutics to provide appropriate treatment, generating positive
outcomes by preventing rapid, repetitive, stimulation of the brain that causes
seizures. According to WHO, globally, around 2.4 million people are anticipated
to be diagnosed with epilepsy every year. Worldwide, approximately, more than
50 million people have epilepsy, thereby making epilepsy a highly common
neurological disease, globally. It is anticipated that 70% people suffering
with epilepsy could live seizure-free if appropriately diagnosed and
effectively treated. Key players offering epilepsy therapeutics in the market
are thriving for approvals for new epilepsy therapeutics from government
bodies, launching more advanced epilepsy therapeutics, providing effective
treatment with fewer side-effects, thus providing an ameliorate product than
the existing products in the market.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2448
Third generation
epilepsy therapeutics is projected to be highly lucrative product segment
According to
Epilepsy Society, anti-epileptic drugs (AEDs) are the main type of treatment
for most people with epilepsy. Up to 70% of people could get rid of seizures
with accurate medication. Anti-epileptic drugs (AEDs) are a type of medication
that aims to prevent seizures from occurring. Third generation epilepsy
therapeutics have been introduced in the last few years, thereby possessing
enhanced pharmacokinetics and pharmacodynamics. Third generation epilepsy
therapeutics have multiple diverse molecular mechanisms of action, thereby
offering a novel and advantageous approach to treat epilepsy, specifically in
patient population undergoing refractory seizures. Furthermore, third
generation epilepsy therapeutics are considered to offer milder adverse
effects, better tolerability, less hormonal or drug interactions, and enhanced
pharmacokinetic characteristics as compared to that of first generation
therapeutics and second generation therapeutics.
Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2448
Hospital pharmacy
segment is estimated to dominate the epilepsy therapeutics market
In terms of
distribution channel, the hospital pharmacy segment held a leading share of the
global epilepsy therapeutics market in 2018. It is anticipated to gain market
share by the end of 2027 and expand at a CAGR of 4.1% during the forecast
period. Surge in incidence of epilepsy, improving epilepsy diagnosis rate,
increasing hospitalization and emergency department visits for epilepsy, rising
number of brain injuries, increasing genetic disorders, congenital defects, and
surging number of neurologists and epileptologists drive the hospital pharmacy
segment of the global epilepsy therapeutics market. Furthermore, rising number
of hospitals and increasing network of key players with hospitals and medical
professionals & related care have led to the dominant share held by the
hospital pharmacy segment of the global epilepsy market.
Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=2448
North America
dominates the global epilepsy therapeutics market, while Asia Pacific offers
significant opportunities.
North America
accounts for key share of the global epilepsy therapeutics market. The market
in the region is likely to expand during the forecast period, due to the rapid
rise in geriatric population, increase in pool of patients, and surge in
research and development to provide more efficient and advanced products.
Moreover, growing numbers of players and their increasing mergers and
acquisitions, rising government approvals for the new products, along with the
growing adoption of advanced products are driving the epilepsy therapeutics
market in North America. The market in Asia Pacific is anticipated to expand at
a rapid pace during the forecast period. Growing geriatric population, rising
prevalence of neurological disorders, increasing research and development,
extensive government initiatives in the healthcare sector, and growing presence
and investments by global key players in Asia pacific are boosting the epilepsy
therapeutics market in the region.
Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2448
Development of
advanced and efficient drugs and rising product approvals are key strategies
adopted by leading players
The report also
provide profiles of leading players functioning in global epilepsy therapeutics
market. UCB S.A., Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals
Inc., and Eisai Co., are leading players operating in the global epilepsy
therapeutics market, which account for a significant share. Companies
functioning in the epilepsy therapeutics market are focused on strengthening
their geographic presence through product approvals by government bodies,
collaborations, strategic acquisitions, and mergers with other market players
in respective domains and geographies. Strong progressive research and
development activities and product pipelines and increasing product approvals
are key strategies adopted by these players in order to consolidate their
position in the global epilepsy therapeutics market.
More Trending Reports by Transparency Market Research:
Red Biotechnology Market: https://www.transparencymarketresearch.com/red-biotechnology-market.html
Pseudomonas Aeruginosa Infection Treatment Market: https://www.transparencymarketresearch.com/pseudomonas-aeruginosa-infections-treatment-market.html
Post-operative Pain Therapeutics Market - https://www.transparencymarketresearch.com/postoperative-pain-therapeutics-market.html
Joint Pain Injections Market - https://www.transparencymarketresearch.com/joint-pain-injection-market.html
Human Microbiome Market - https://www.transparencymarketresearch.com/india-human-microbiome-market.html
Water for Injection Market - https://www.transparencymarketresearch.com/water-for-injection-market.html
Venous Diseases Treatment Market - https://www.transparencymarketresearch.com/venous-diseases-treatment-market.html
About Us
Transparency
Market Research, a global market research company registered at Wilmington,
Delaware, United States, provides custom research and consulting services. The
firm scrutinizes factors shaping the dynamics of demand in various
markets. The insights and perspectives on the markets evaluate
opportunities in various segments. The opportunities in the segments based on
source, application, demographics, sales channel, and end-use are analysed,
which will determine growth in the markets over the next decade.
Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision-makers, made possible by
experienced teams of Analysts, Researchers, and Consultants. The proprietary
data sources and various tools & techniques we use always reflect the
latest trends and information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our
YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
No comments:
Post a Comment